Immunotherapy / PD-1 inhibitorPhase 3 trialInvestigational
Zoliflodine
How it works
Blocks a protein that helps cancer cells evade the immune system, allowing the immune system to attack and destroy cancer cells.
Cancer types
Ovarian Cancer— All patients
Efficacy
Clinical trials are ongoing to evaluate the efficacy of zoliflodine in ovarian cancer patients.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.